344 related articles for article (PubMed ID: 22354000)
41. Central nervous system complications and management in sickle cell disease.
DeBaun MR; Kirkham FJ
Blood; 2016 Feb; 127(7):829-38. PubMed ID: 26758917
[TBL] [Abstract][Full Text] [Related]
42. Acute silent cerebral ischemia and infarction during acute anemia in children with and without sickle cell disease.
Dowling MM; Quinn CT; Plumb P; Rogers ZR; Rollins NK; Koral K; Buchanan GR
Blood; 2012 Nov; 120(19):3891-7. PubMed ID: 22948048
[TBL] [Abstract][Full Text] [Related]
43. Blood transfusion for preventing primary and secondary stroke in people with sickle cell disease.
Estcourt LJ; Kohli R; Hopewell S; Trivella M; Wang WC
Cochrane Database Syst Rev; 2020 Jul; 7(7):CD003146. PubMed ID: 32716555
[TBL] [Abstract][Full Text] [Related]
44. Blood transfusion for preventing primary and secondary stroke in people with sickle cell disease.
Estcourt LJ; Fortin PM; Hopewell S; Trivella M; Wang WC
Cochrane Database Syst Rev; 2017 Jan; 1(1):CD003146. PubMed ID: 28094851
[TBL] [Abstract][Full Text] [Related]
45. Practice patterns for neuroimaging and transfusion therapy for management of neurologic complications in sickle cell anemia: DISPLACE consortium.
Phillips S; Schlenz AM; Mueller M; Melvin C; Adams RJ; Kanter J;
Pediatr Blood Cancer; 2020 Nov; 67(11):e28569. PubMed ID: 32894002
[TBL] [Abstract][Full Text] [Related]
46. Cognitive screening examinations for silent cerebral infarcts in sickle cell disease.
DeBaun MR; Schatz J; Siegel MJ; Koby M; Craft S; Resar L; Chu JY; Launius G; Dadash-Zadeh M; Lee RB; Noetzel M
Neurology; 1998 Jun; 50(6):1678-82. PubMed ID: 9633710
[TBL] [Abstract][Full Text] [Related]
47. Intracranial vasculopathy and infarct recurrence in children with sickle cell anaemia, silent cerebral infarcts and normal transcranial Doppler velocities.
Choudhury NA; DeBaun MR; Ponisio MR; Jordan LC; Rodeghier M; Pruthi S; McKinstry RC
Br J Haematol; 2018 Oct; 183(2):324-326. PubMed ID: 29076125
[TBL] [Abstract][Full Text] [Related]
48. Hydroxycarbamide treatment and brain MRI/MRA findings in children with sickle cell anaemia.
Nottage KA; Ware RE; Aygun B; Smeltzer M; Kang G; Moen J; Wang WC; Hankins JS; Helton KJ
Br J Haematol; 2016 Oct; 175(2):331-338. PubMed ID: 27604981
[TBL] [Abstract][Full Text] [Related]
49. Accuracy of neurologic examination and history in detecting evidence of MRI-diagnosed cerebral infarctions in children with sickle cell hemoglobinopathy.
Glauser TA; Siegel MJ; Lee BC; DeBaun MR
J Child Neurol; 1995 Mar; 10(2):88-92. PubMed ID: 7782614
[TBL] [Abstract][Full Text] [Related]
50. Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography.
Adams RJ; McKie VC; Hsu L; Files B; Vichinsky E; Pegelow C; Abboud M; Gallagher D; Kutlar A; Nichols FT; Bonds DR; Brambilla D
N Engl J Med; 1998 Jul; 339(1):5-11. PubMed ID: 9647873
[TBL] [Abstract][Full Text] [Related]
51. Parent education and biologic factors influence on cognition in sickle cell anemia.
King AA; Strouse JJ; Rodeghier MJ; Compas BE; Casella JF; McKinstry RC; Noetzel MJ; Quinn CT; Ichord R; Dowling MM; Miller JP; Debaun MR
Am J Hematol; 2014 Feb; 89(2):162-7. PubMed ID: 24123128
[TBL] [Abstract][Full Text] [Related]
52. Red blood cell transfusion to treat or prevent complications in sickle cell disease: an overview of Cochrane reviews.
Fortin PM; Hopewell S; Estcourt LJ
Cochrane Database Syst Rev; 2018 Aug; 8(8):CD012082. PubMed ID: 30067867
[TBL] [Abstract][Full Text] [Related]
53. History of parvovirus B19 infection is associated with silent cerebral infarcts.
Ogunsile FJ; Currie KL; Rodeghier M; Kassim A; DeBaun MR; Sharma D
Pediatr Blood Cancer; 2018 Jan; 65(1):. PubMed ID: 28834316
[TBL] [Abstract][Full Text] [Related]
54. Using novel magnetic resonance imaging methods to predict stroke risk in individuals with sickle cell anemia.
Jordan LC; Kassim AA; Wilkerson KL; Lee CA; Waddle SL; Donahue MJ
Hematol Oncol Stem Cell Ther; 2020 Jun; 13(2):76-84. PubMed ID: 32192979
[TBL] [Abstract][Full Text] [Related]
55. Silent cerebral infarcts in sickle cell anemia: a risk factor analysis. The Cooperative Study of Sickle Cell Disease.
Kinney TR; Sleeper LA; Wang WC; Zimmerman RA; Pegelow CH; Ohene-Frempong K; Wethers DL; Bello JA; Vichinsky EP; Moser FG; Gallagher DM; DeBaun MR; Platt OS; Miller ST
Pediatrics; 1999 Mar; 103(3):640-5. PubMed ID: 10049969
[TBL] [Abstract][Full Text] [Related]
56. Incidence of overt and covert neurological damage in children with sickle cell disease.
Hindmarsh PC; Brozovic M; Brook CG; Davies SC
Postgrad Med J; 1987 Sep; 63(743):751-3. PubMed ID: 3444798
[TBL] [Abstract][Full Text] [Related]
57. Prevalence of intracranial stenosis and silent cerebral infarcts in children with sickle cell anemia and low risk of stroke.
Arkuszewski M; Krejza J; Chen R; Ichord R; Kwiatkowski JL; Bilello M; Zimmerman R; Ohene-Frempong K; Melhem ER
Int J Stroke; 2013 Oct; 8(7):E50-1. PubMed ID: 24024926
[No Abstract] [Full Text] [Related]
58. Abnormalities of the central nervous system in very young children with sickle cell anemia.
Wang WC; Langston JW; Steen RG; Wynn LW; Mulhern RK; Wilimas JA; Kim FM; Figueroa RE
J Pediatr; 1998 Jun; 132(6):994-8. PubMed ID: 9627592
[TBL] [Abstract][Full Text] [Related]
59. White Matter Integrity in Tanzanian Children With Sickle Cell Anemia: A Diffusion Tensor Imaging Study.
Jacob M; Stotesbury H; Kawadler JM; Lapadaire W; Saunders DE; Sangeda RZ; Chamba C; Kazema R; Makani J; Kirkham FJ; Clark CA
Stroke; 2020 Apr; 51(4):1166-1173. PubMed ID: 32138633
[TBL] [Abstract][Full Text] [Related]
60. Multicenter comparison of magnetic resonance imaging and transcranial Doppler ultrasonography in the evaluation of the central nervous system in children with sickle cell disease.
Wang WC; Gallagher DM; Pegelow CH; Wright EC; Vichinsky EP; Abboud MR; Moser FG; Adams RJ
J Pediatr Hematol Oncol; 2000; 22(4):335-9. PubMed ID: 10959904
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
